Patents
Sitemap › A61 - Medical or veterinary science; Hygiene › A61P - Specific therapeutic activity of chemical compounds or medicinal preparations › A61P 19 - Drugs for skeletal disorders
Patents for A61P 19 - Drugs for skeletal disorders (81,981)
10/2009
10/28/2009EP1850830B1 Suppository for binding of reactive oxygen compounds in human and animal bodies
10/28/2009EP1503800B1 Treatment and prevention of tissue damage associated with increased c-reactive protein production
10/28/2009EP1379504B1 Bipiperidinyl-derivatives and their use as chemokine receptors inhibitors
10/28/2009EP1371377B1 Compositions for gene therapy of rheumatoid arthritis including a gene encoding an anti-angiogenic protein or parts thereof
10/28/2009EP1272168B2 Small organic molecule regulators of cell proliferation
10/28/2009CN101565423A Thienopyridine derivatives, production method and use thereof
10/28/2009CN101564515A Bony spur preparation and preparation method thereof
10/28/2009CN101564501A Big activating collateral preparation and preparation method thereof
10/28/2009CN101564496A Plaster for mainly curing osteoarthropathy and soft tissue injury
10/28/2009CN101564487A Jiehong medicine for injuries from falls and preparation method thereof
10/28/2009CN101564481A Bone-setting anti-bruise powder preparation and preparation method thereof
10/28/2009CN101564477A Small activating collateral preparation and preparation method thereof
10/28/2009CN101564474A Foot soaking preparation for treating gout and preparation method thereof
10/28/2009CN101564467A Physalis alkekengi nanometer powder capsule for treating gout and preparation method thereof
10/28/2009CN101564462A Chinese medicament for treating diabetic osteoporosis
10/28/2009CN101564433A Chinese medicinal composition for treating rheumatic diseases, and preparation method thereof
10/28/2009CN101564422A Chinese medicament for treating diabetic gout
10/28/2009CN101564382A Iguratimod osmotic pump controlled slow-release preparation
10/28/2009CN100554263C Novel method of producing strontium ranelate heptahydrate
10/28/2009CN100554226C Preparation method of estrogen activity-possessed red clover extractive
10/28/2009CN100553674C Medicinal composition of recombinant human parathormone(1-84) and its preparing process
10/28/2009CN100553644C Composition containing pearl and vitamin and its use
10/28/2009CN100553640C Novel method for externally applied glucosamine for the treatment of arthritis and externally applied formulation of glucosamine
10/28/2009CN100553637C Hormone composition
10/28/2009CN100553631C Pharmaceutical uses of 4-fluoro-N-(1,2- hydrindenl-2-yl) benzamide
10/27/2009US7610097 Electromagnetic stimulation in patients with osteoporosis
10/27/2009US7608683 Human leukocyte antigen pan DR-binding peptides for use in the treatment of infections, inflammatory, autoimmune and cancer diseases; has heat shock protein that is capable of binding to MHC class II molecules
10/27/2009US7608638 Tocopherols, tocotrienols, other chroman and side chain derivatives and uses thereof
10/27/2009US7608637 Prevention and treatment of bone disorders with EP4 agonistfor compounds posessing prostaglandins structure
10/27/2009US7608625 Method for treating bruxism and bruxism-related diseases
10/27/2009US7608610 Transdermal formulation containing androgen, macrocyclic ester or ketone enhancer and thickener; extended time high blood serum concentration; rapidly absorbed gel; treatment of male hypogonadism
10/27/2009US7608609 Pharmaceutical composition
10/27/2009US7608608 Pharmaceutical composition
10/27/2009US7608607 Pharmaceutical composition
10/27/2009US7608606 Transdermal formulation containing androgen, macrocyclic ester or ketone enhancer and thickener; extended time high blood serum concentration; rapidly absorbed gel; treatment of male hypogonadism
10/27/2009US7608605 Transdermal formulation containing androgen, macrocyclic ester or ketone enhancer and thickener; extended time high blood serum concentration; rapidly absorbed gel; treatment of male hypogonadism
10/27/2009US7608603 preferential enzyme inhibitors comprising fused pyrazolo pyrimidine derivatives used for treating arthritis, Crohns disease, irritable bowel syndrome, adult respiratory distress syndrome, or chronic obstructive pulmonary disease
10/27/2009US7608580 Osteogenic protein such as Bone Morphogenic Protein, hyaluronic acid derivatives and porogen or sodium bicarbonate; bone repair, or tendon, cartilage repair; allows for closed fracture repair
10/27/2009US7608452 Polynucleotides encoding cytokine receptor zcytor19
10/27/2009US7608281 Retinoic acid receptors (RAR); tissue engineering, cartilage formation; for treatment of cartilage degenerative disease, skeletal trauma; bone morphogenetic protein (BMP), osteogenic protein (OP)
10/27/2009US7608245 Transmission and, or amplification of signal ; oral or enteric administering; dissolving; absorption by small inteestines; peptide yy; obesity therapy
10/27/2009CA2471565C Use of a gsk-3beta inhibitor in the manufacture of a medicament for increasing bone formation
10/27/2009CA2466724C Benzamide and heteroarylamide as p2x7 receptor antagonists
10/27/2009CA2432713C Aniline derivatives or salts thereof and cytokine production inhibitors containing the same
10/27/2009CA2376355C N-heterocyclic derivatives as nos inhibitors
10/27/2009CA2365204C Lipoxin compounds and their use
10/27/2009CA2349529C Pge synthase and methods and means for modulating its activity
10/27/2009CA2318145C Sulfonylamino derivatives which inhibit matrix-degrading metalloproteinases
10/27/2009CA2300415C Composition and device for in vivo cartilage repair
10/22/2009WO2009129433A2 Alpha adrenergic receptor agonists for treatment of degenerative disc disease
10/22/2009WO2009129408A2 Compositions and methods for treating pathologic angiogenesis and vascular permeability
10/22/2009WO2009129260A2 Calycosin and analogs thereof for the treatment of estrogen receptor beta-mediated diseases
10/22/2009WO2009129246A2 Compositions and methods for preparing and using same
10/22/2009WO2009129148A2 Methods and compositions for treating intervertebral disc herniations
10/22/2009WO2009128558A1 Activator for peroxisome proliferator-activated receptor
10/22/2009WO2009128521A1 Cysteine protease inhibitor
10/22/2009WO2009128520A1 Heterocyclic compound having inhibitory activity on p13k
10/22/2009WO2009128481A1 Nitrogenated 5-membered heterocyclic compound
10/22/2009WO2009128395A1 Bone formation promoter comprising 2-aminophenol or derivative thereof as active ingredient
10/22/2009US20090265798 Desaturase genes and uses thereof
10/22/2009US20090264624 Human cytokine receptor
10/22/2009US20090264518 Liquid koji and quick-brewed miso-like food
10/22/2009US20090264515 Polynucleotide therapy
10/22/2009US20090264455 Androgen Receptor Modulator Compounds and Methods
10/22/2009US20090264452 2-(Phenylamino)-Pyrimidin-5-Amides As Cannabinoid 2 Receptors Modulators for the Treatment of Immune or Inflammatory Disorders
10/22/2009US20090264424 Vanilloid receptor ligands and their use in treatments
10/22/2009US20090264415 Pyrido(3,2-d)pyrimidines and pharmaceutical compositions useful for medical treatment
10/22/2009US20090264384 Indole, benzimidazole, and benzolactam boronic acid compounds, analogs thereof and methods of use thereof
10/22/2009US20090264370 Polypeptides homologous to vegf and bmp1
10/22/2009US20090264367 5-cnac as oral delivery agent for parathyroid hormone fragments
10/22/2009US20090264366 Transglutaminase Mediated Conjugation of Peptides
10/22/2009US20090264365 Conformationally constrained parathyroid hormone (pth) analogs
10/22/2009US20090264364 Genes implicated in the regulation of angiogenesis, pharmaceutical preparations containing them and their applications
10/22/2009US20090264345 Macrocyclic peptides and methods for making and using them
10/22/2009US20090263883 Recombinant Parainfluenza Virus Expression Systems And Vaccines Comprising Heterologous Antigens Derived From Respiratory Syncytial Virus
10/22/2009US20090263847 Lsr receptor, its activity, its cloning and its applications to the diagnosis, prevention and/or treatment of obesity and related risks or complications
10/22/2009US20090263474 Methods for Treating Autoimmune Diseases in a Subject and In Vitro Diagnostic Assays
10/22/2009US20090263459 Methods and compositions for treating intervertebral disc herniations
10/22/2009US20090263446 Method of making load bearing hydrogel implants
10/22/2009US20090263404 Methods and Compositions for Using MHC Class II Invariant Chain Polypeptide as a Receptor for Macrophage Migration Inhibitory Factor
10/22/2009US20090263401 USES OF IL-174 ANTAGONISTS FOR INHIBITING A Th2 IMMUNE RESPONSE
10/22/2009US20090263363 Compositions and Methods For Treating Bone Formation Disorders
10/22/2009US20090263358 autologously transplanting hematopoietic progenitor cell population which has been treated with antibody (monoclonal, chimeric, or humanized; not conjugated to toxin or cytolytic agent); radiotherapy
10/22/2009US20090263320 Peptide-Based Compounds
10/22/2009CA2721507A1 Methods of generating and using procollagen
10/22/2009CA2721339A1 Activating agent for peroxisome proliferator activated receptor
10/22/2009CA2721269A1 Compounds and methods for altering bone growth
10/22/2009CA2721191A1 Calycosin and analogs thereof for the treatment of estrogen receptor beta-mediated diseases
10/22/2009CA2720671A1 Compositions and methods for preparing and using same
10/22/2009CA2693001A1 Compositions and methods for treating pathologic angiogenesis and vascular permeability
10/21/2009EP2110142A2 Inhibition of secretion from non-neuronal cells
10/21/2009EP2109611A1 7-azaindole derivatives and their use in the inhibition of c-jun n-terminal kinase
10/21/2009EP2109607A1 Pyrrolo[3, 2-a]pyridine derivatives for inhibiting ksp kinesin activity
10/21/2009EP2109444A1 Bone growth particles and osteoinductive composition thereof
10/21/2009EP2109440A2 Association of compounds inhibiting melanogenesis and use thereof in cosmetics and dermatology
10/21/2009EP1776138B1 tRNA SYNTHETASE FRAGMENTS
10/21/2009EP1682226B1 A lipid preparation for enhancing mineral absorption
10/21/2009EP1513531B1 Basic non-peptide bradykinin antagonists and pharmaceutical compositions therefrom
10/21/2009EP1450750B1 Use of 2-amino-4-pyridylmethyl-thiazoline derivatives as inhibitors of inducible no-synthase
10/21/2009EP1280776B1 Substituted benzoic acid amides and use thereof for the inhibition of angiogenesis
1 ... 256 257 258 259 260 261 262 263 264 265 266 267 268 269 270 271 272 273 274 275 276 ... 820